Developing folate-conjugated miR-34a therapeutic for prostate cancer treatment: Challenges and promises.
Li WJ, Wang Y, Liu X, Wu S, Wang M, Turowski SG, Spernyak JA, Tracz A, Abdelaal AM, Sudarshan K, Puzanov I, Chatta G, Kasinski AL, Tang DG.
Li WJ, et al. Among authors: wu s.
bioRxiv [Preprint]. 2024 Jan 21:2023.11.25.568612. doi: 10.1101/2023.11.25.568612.
bioRxiv. 2024.
PMID: 38045265
Free PMC article.
Updated.
Preprint.